1. Home
  2. FISI vs IRWD Comparison

FISI vs IRWD Comparison

Compare FISI & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Financial Institutions Inc.

FISI

Financial Institutions Inc.

BUY

Current Price

$39.67

Market Cap

804.4M

Sector

Finance

ML Signal

BUY

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.65

Market Cap

687.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FISI
IRWD
Founded
1817
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
804.4M
687.4M
IPO Year
1999
2009

Fundamental Metrics

Financial Performance
Metric
FISI
IRWD
Price
$39.67
$3.65
Analyst Decision
Hold
Buy
Analyst Count
2
4
Target Price
★ $45.00
$6.10
AVG Volume (30 Days)
105.8K
★ 1.7M
Earning Date
10-29-2026
11-09-2026
Dividend Yield
★ 3.20%
N/A
EPS Growth
231.27
★ 1400.00
EPS
★ 2.08
0.55
Revenue
N/A
★ $298,276,000.00
Revenue This Year
$6.51
$59.19
Revenue Next Year
$4.63
$4.80
P/E Ratio
$18.98
★ $6.84
Revenue Growth
N/A
★ 8.88
52 Week Low
$25.61
$1.41
52 Week High
$42.97
$5.78

Technical Indicators

Market Signals
Indicator
FISI
IRWD
Relative Strength Index (RSI) 43.26 34.30
Support Level $37.78 $3.04
Resistance Level $40.33 $3.96
Average True Range (ATR) 0.80 0.19
MACD -0.11 -0.07
Stochastic Oscillator 51.52 8.61

Price Performance

Historical Comparison
FISI
IRWD

About FISI Financial Institutions Inc.

Financial Institutions Inc operates through its subsidiaries, providing full range of banking services to consumer, commercial and municipal customers in Western and Central New York, and commercial loans in the Mid-Atlantic region, through a loan production office in Ellicott City, Maryland. It offers a broad range of loans including commercial business and revolving lines of credit, commercial mortgages, equipment loans, residential mortgage loans and home equity loans and lines of credit, automobile loans and personal loans. It operates in single segment of Banking.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: